In ongoing litigation unfolding in New Jersey, a Chinese drug manufacturer has sought dismissal of a claim by Janssen, the pharmaceutical subsidiary of Johnson and Johnson. Janssen accusses the Chinese enterprise of contriving a conspiracy with its own subsidiary in an attempt to illicitly misappropriate trade secrets.
As reported by Ken Downey Jr. on Law360, court filings reveal that the Chinese firm has petitioned to a federal judge in New Jersey in order to dismiss the allegations.
For those professionals immersed in legal issues surrounding intellectual property rights and international trade, the outcome of this case could certainly influence the landscape for multinational corporations across the globe.